Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Completed

Conditions studied: Ewing's Sarcoma, Leukemia, Lymphoma, Brain Tumors, Rhabdomyosarcoma

In brief

This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.

Key facts

Study ID

NCT00001686

Run by

National Cancer Institute (NCI)

People needed

482

Starts

1998-03-19

Expected to finish

2020-09-02

Last updated by the study team

2020-09-10

Who can join

Age: 2 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Patients younger than 2 years of age.
• Patients weighing less than or equal to 12 kg.
• Pregnant women are excluded from enrollment onto this study because the invasive procedures and/or sedation needed to perform these may cause unnecessary harm to the unborn fetus. In the event a woman becomes pregnant while on study, she will not be removed from the study; however, no invasive clinical or research procedures will be done or cancer treatment provided during pregnancy that include unacceptable risk to the patient and/or to the unborn fetus.

Where it is running

• National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.